Evoke Pharma Inc

NASDAQ:EVOK   3:59:43 PM EDT
1.36
+0.01 (+0.74%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)44.03M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.15 Million
Adjusted EPS-$0.08
See more estimates
10-Day MA$1.36
50-Day MA$1.47
200-Day MA$2.92
See more pivots

Evoke Pharma Inc Stock, NASDAQ:EVOK

420 Stevens Avenue, Suite 370, Solana Beach, California 92075
United States of America
Phone: +1.858.345.1494
Number of Employees: 5

Description

Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.